Human papillomavirus (HPV) vaccines, which were introduced in many countries in the past
decade, have shown promising results in decreasing HPV infection and related diseases …

The discovery of genotype 16 as the prototype oncogenic human papillomavirus (HPV)
initiated a quarter century of laboratory and epidemiological studies that demonstrated their …

Background Modelling studies have been widely used to inform human papillomavirus
(HPV) vaccination policy decisions; however, many models exist and it is not known whether …

The current global novel coronavirus disease 2019 (COVID-19) pandemic threatens to
derail the uptake of human papillomavirus (HPV) vaccination in low-and lower-middle …

HPV-related diseases represent a major cause of morbidity and mortality, although effective
HPV vaccines are available, potentially allowing for the elimination of these malignancies …

Human papillomavirus (HPV) infection is responsible for many cancers in both women and
men. Cervical cancer, caused by HPV, is the fourth most common cancer among women …

With major advances in understanding the infectious etiology of cervical cancer, preventive
medicine has obtained highly promising new tools. Human papillomavirus (HPV) vaccines …

Abstract The Human Papillomavirus Prevention and Control Board brought together experts
to discuss optimizing HPV vaccination and screening programs. Board members reviewed …

In 2018, WHO called for global action to eliminate cervical cancer. The complexity of the
processes involved in terms of prevention is often underestimated. Low‐and middle‐income …

Introduction Cervical cancer has been considered as one of the most common cancers in
women (15–44 years) globally, but the advent of the human papilloma virus (HPV) vaccine …